Medication info

Acyvir Tablets (Acyclovir)

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Ahn-guk New Pharm Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201903179 · Approved 2019.05.16

This product's status changed to Expired on 2024.05.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, administration is preferably started at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.
Child administration
○ Pediatric patients 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Use the adult dosage. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years: Administer 1/2 of the adult dose. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Ahn-guk New Pharm Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes simplex virus infections
  • shingles virus infections
  • acute pain
  • chickenpox.
View approved original text

This medicine treats and prevents infections caused by the herpes simplex virus, including primary and recurrent genital herpes. It is also effective for relief of acute pain from shingles virus infections. However, its effectiveness for postherpetic neuralgia has not yet been clearly established. Additionally, it is used for the treatment of chickenpox in children over 2 years old. It helps effectively treat a variety of viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, administration is preferably started at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.

Child administration

○ Pediatric patients 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Use the adult dosage. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years: Administer 1/2 of the adult dose. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medicine should not be used in certain patients. It could be dangerous for patients who are allergic to this medicine or its ingredients, or who have a genetic disease that impairs the breakdown of lactose. Patients with poor kidney or liver function, young children, and older adults should use this medicine with caution. Especially in cases of weakened kidney function, there is a higher likelihood of neurological symptoms appearing, so caution is required. During treatment, severe allergic reactions or skin rashes, fever, blisters, etc. may rarely occur, so if these symptoms appear, discontinue use immediately and consult a healthcare professional. Various neurological symptoms such as confusion, hallucinations, seizures, drowsiness, and anxiety can occur, which may occur more frequently in older patients or those with impaired kidney function. Adverse effects such as decreased kidney function, hepatitis, gastrointestinal disturbances, blood abnormalities, muscle pain, and cardiac arrhythmias have been reported, so if there are unusual symptoms, notify a healthcare professional immediately. To maximize treatment effectiveness, it is important to start taking the medication early when symptoms first appear, particularly in the case of chickenpox or herpes where it should be taken as soon as possible after symptoms develop. Adequate hydration is necessary while taking this medication, and especially with high doses, it is important to drink plenty of water to prevent kidney toxicity. Caution is necessary when driving or operating hazardous machinery as consciousness disturbances may occur. This medicine can interact with other drugs, so you must inform your healthcare professional about any other medications you are currently taking, especially when taking medications that affect kidney function as there is an increased risk of kidney deterioration. Women who are pregnant or may become pregnant should use this medicine cautiously, and those who are breastfeeding are advised to discontinue use. In young children or infants, it should only be used minimally and as needed, and elderly patients may need dose adjustments due to increased drug levels from reduced kidney function.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reactions
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 118 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • hepatic impairment
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • fecal incontinence
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • state of coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is important to store it in a cool, dry place below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.